Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

(2015) Mads Duus Hjortsø et al.   OncoImmunology

Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.

(2014) Benoit Marchand et al.   CANCER RESEARCH

The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity

(2014) S M Ahmad et al.   Blood Cancer Journal

Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase

(2013) T. Z. Iversen et al.   CLINICAL CANCER RESEARCH

Functional characterization of Foxp3-specific spontaneous immune responses

(2013) S K Larsen et al.   LEUKEMIA

Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells

(2013) S Munir et al.   LEUKEMIA

Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway

(2013) S M Ahmad et al.   LEUKEMIA

Immunologic Targeting of FOXP3 in Inflammatory Breast Cancer Cells

(2013) Smita Nair et al.   PLoS One

FOXP3-specific immunity

(2013) Mads Andersen   OncoImmunology

The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+T cells

(2013) Shamaila Munir et al.   OncoImmunology

Selection of Self-Reactive T Cells in the Thymus

(2012) Gretta L. Stritesky et al.   Annual Review of Immunology

The role of B7 family molecules in hematologic malignancy

(2012) P. Greaves et al.   BLOOD

The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase

(2012) Mads Hald Andersen   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells

(2012) Arthur A. Hurwitz et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)

(2012) Suzanne Ostrand-Rosenberg et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment

(2012) Z. Zhu et al.   CANCER RESEARCH

Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma

(2012) H Tamura et al.   LEUKEMIA

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase

(2012) Shamaila Munir et al.   PLoS One

CD4 responses against IDO

(2012) Mads Hald Andersen   OncoImmunology

FOXO3

(2012) Stephanie K. Watkins et al.   OncoImmunology

Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2

(2011) R. B. Sorensen et al.   CANCER RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

(2011) Stephanie K. Watkins et al.   JOURNAL OF CLINICAL INVESTIGATION

Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma

(2011) N W C J van de Donk et al.   LEUKEMIA

Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome

(2011) T Krejsgaard et al.   LEUKEMIA

Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells

(2011) P Amé-Thomas et al.   LEUKEMIA

Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

(2011) Per thor Straten et al.   VACCINE

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

(2010) R. B. Sorensen et al.   BLOOD

Identification of heme oxygenase-1–specific regulatory CD8+ T cells in cancer patients

(2009) Mads Hald Andersen et al.   JOURNAL OF CLINICAL INVESTIGATION

The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase

(2009) Rikke Bæk Sørensen et al.   PLoS One

Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer

(2009) L. A. Vella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients

(2008) T Kozako et al.   LEUKEMIA

Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan

(2008) Yoshika Nagata et al.   LUNG CANCER

Immune escape as a fundamental trait of cancer: focus on IDO

(2008) G C Prendergast   ONCOGENE

Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation

(2008) H. Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA